Taxing Health: The relevance of tariff revenue from anti-malarial commodities (en)

Paper dealing with potential fiscal revenue losses in malaria endemic countries, resulting from elimination of import duties and tariffs on anti-malaria products (medicines for treating/preventing of malaria, diagnostic tests, mosquito nets, insecticides for indoor residual spraying, and pumps for spraying indoor insecticides); examines the size of possible fiscal revenue losses if tariff rates on such products were cut off in countries with high and medium malaria endemic rates. 
Télécharger le document